XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

136 hedge funds and large institutions have $1.02B invested in Acceleron Pharma Inc. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+8
Holders Change %
+6.25%
% of All Funds
3.63%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
26
Increased
54
Reduced
35
Closed
17
Calls
$870K
Puts
$4.28M
Net Calls
-$3.41M
Net Calls Change
+$1.21M

Top Buyers

1
PAMU
1
Pictet Asset Management (UK)
United Kingdom
$24.9M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$16.8M
3
CS
3
Credit Suisse
Switzerland
$13.2M
4
Goldman Sachs
4
Goldman Sachs
New York
$14.2M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$107M

Top Sellers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$17.7M
2
DM
2
Deerfield Management
New York
$0
3
PA
3
Perceptive Advisors
New York
$20.5M
4
ORI
4
Oak Ridge Investments
Illinois
$45.6M
5
FCMI
5
Foresite Capital Management II
California
$1.66M
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
151
Group One Trading
Illinois
– -$15K -561 Closed
TRCT
152
Tower Research Capital (TRC)
New York
– -$1K -20 Closed
3 4 5 6
7